Multiple sclerosis
On this page:
The Ottawa Hospital is conducting cutting-edge research to improve our understanding of multiple sclerosis and develop better treatments. This page includes selected news stories about our multiple sclerosis research, links to researchers working in this area and related resources. Learn more below.
Research & News
Labs and Groups
These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team.
Aviv Advanced Imaging Lab
Cognitive Health in Multiple Sclerosis Research Lab
Fadda Lab
Kothary Lab
Picketts Lab
Clinical Trials
The following list of clinical trials at The Ottawa Hospital is pulled from ClinicalTrials.gov, which is hosted by the U.S. National Library of Medicine and only available in English. If you find a clinical trial that interests you, you can bring the information to the next appointment with your care team and ask if you are eligible for the study. If so, they may be able to refer you to the study team. If you email the study team directly, we can guarantee a response. Learn more about participating in research and clinical trials.
A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition (NCT05781113)
Multiple Sclerosis View DetailsComparison Between ABP 692 and Ocrevus® (Ocrelizumab) (NCT06700343)
Relapsing-remitting Multiple Sclerosis (RRMS) View DetailsPublications
The following research publications from The Ottawa Hospital are pulled from PubMed, with publication date of 2020 or later. Note that PubMed is hosted by the U.S. National Library of Medicine and is only available in English.
Spinal Cord Leptomeningeal Enhancement as a Marker of Extensive Spinal Cord Involvement in Children With MOGAD.
2026-01-01 Go to publicationQuality and Scope of Published International Guidelines for Multiple Sclerosis Care: AGREE II Appraisal.
2025-11-01 Go to publicationClinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
2025-11-01 Go to publicationSubjective cognitive fatigability is associated with worse patient-reported physical disability in multiple sclerosis.
2025-11-01 Go to publicationBlood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
2025-10-15 Go to publication